← FDA DRUG APPROVALS
FDA ANDA · ANDA216569
CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%
Sponsor: SCIEGEN PHARMS
APPLICATION
ANDA216569
TYPE
ANDA
ORIGINAL APPROVAL
2023-10-16
LATEST ACTION
2023-10-16
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
CLOTRIMAZOLEPrescription
CLOTRIMAZOLE 1% · SOLUTION · TOPICAL
Approval history
2023-10-16UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.